ABT
ABBOTT LABORATORIESD4615-min delayed · EOD close108.79 −1.52% downas of 2026-09-03mkt cap $189B
Pharmaceutical Preparations · SIC 2834 · CIK 0000001800
Quality score
46/100
D
Growth18
Business quality46
missing: grossMargin
Financial healthno data
missing: debtToEquity, cashToLiabilities
Valuation74
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Mixed picture
Highly uneven
Strongest on valuation (74), weakest on growth (18). The composite is the mean of the sub-scores that could be computed. 3 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
7.6%
year over year
Earnings growth
-53.2%
year over year